Novartis appoints Federico Mambretti as Country President for Italy

Novartis has announced the appointment of Federico Mambretti as Country President for Italy, effective September 1. Mambretti succeeds Valentino Confalone, who has led the Italian organization for the past four years.

Mambretti returns to Italy following a tenure as Country President for Belgium and Luxembourg, where he focused on organizational growth and accelerating access to medical innovation. His professional background spans the pharmaceutical, medtech, consumer, and management consulting sectors.

In his new role, Mambretti aims to strengthen collaboration with scientific communities, healthcare institutions, and patient associations. The company intends to focus on scientific innovation to ensure treatments are accessible to Italian patients in an equitable and timely manner.